Next Article in Journal
Finding New Enzymes from Bacterial Physiology: A Successful Approach Illustrated by the Detection of Novel Oxidases in Marinomonas mediterranea
Next Article in Special Issue
Conventional and Unconventional Antimicrobials from Fish, Marine Invertebrates and Micro-algae
Previous Article in Journal
Synthesis of 3-Alkyl Pyridinium Alkaloids from the Arctic Sponge Haliclona viscosa
Previous Article in Special Issue
Anti-Parasitic Compounds from Streptomyces sp. Strains Isolated from Mediterranean Sponges
Mar. Drugs 2010, 8(3), 498-518; doi:10.3390/md8030498

Novel Anti-Infective Compounds from Marine Bacteria

1,2,* , 1
1 School of Life Sciences, Heriot-Watt University, Riccarton, Edinburgh EH14 4AS, Scotland, UK 2 Institute of Aquaculture, University of Stirling, Stirling, FK9 4LA, Scotland, UK 3 Department of Chemistry, School of Engineering and Physical Sciences, Heriot-Watt University, Riccarton, Edinburgh EH14 4AS, Scotland, UK 4 Aquapharm Biodiscovery Limited, European Centre for Marine Biotechnology, Dunstaffnage Marine Laboratory, Oban, Argyll PA37 1QA, Scotland, UK
* Author to whom correspondence should be addressed.
Received: 3 February 2010 / Revised: 1 March 2010 / Accepted: 2 March 2010 / Published: 5 March 2010
(This article belongs to the Special Issue Marine Anti-infective Agents)


As a result of the continuous evolution of microbial pathogens towards antibiotic-resistance, there have been demands for the development of new and effective antimicrobial compounds. Since the 1960s, the scientific literature has accumulated many publications about novel pharmaceutical compounds produced by a diverse range of marine bacteria. Indeed, marine micro-organisms continue to be a productive and successful focus for natural products research, with many newly isolated compounds possessing potentially valuable pharmacological activities. In this regard, the marine environment will undoubtedly prove to be an increasingly important source of novel antimicrobial metabolites, and selective or targeted approaches are already enabling the recovery of a significant number of antibiotic-producing micro-organisms. The aim of this review is to consider advances made in the discovery of new secondary metabolites derived from marine bacteria, and in particular those effective against the so called “superbugs”, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin resistant enterococci (VRE), which are largely responsible for the increase in numbers of hospital acquired, i.e., nosocomial, infections.
Keywords: marine bacteria; MRSA; VRE; hospital superbugs; new scaffolds; antibiotic resistance; nosocomial infection marine bacteria; MRSA; VRE; hospital superbugs; new scaffolds; antibiotic resistance; nosocomial infection
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
MDPI and ACS Style

Rahman, H.; Austin, B.; Mitchell, W.J.; Morris, P.C.; Jamieson, D.J.; Adams, D.R.; Spragg, A.M.; Schweizer, M. Novel Anti-Infective Compounds from Marine Bacteria. Mar. Drugs 2010, 8, 498-518.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


Cited By

[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert